LONG-TERM EFFICACY OF EVINACUMAB IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: RESULTS FROM SUBGROUP ANALYSES

• Autore principale: Daniel Gaudet, MD, PhD (Autore)
• Natura: Libro
• Pubblicazione: Elsevier, 2024-09-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Therapeutic Area: Pharmacologic Therapy Background: Homozygous familial hypercholesterolemia (HoFH) is a rare genetic disorder characterized by severely elevated low-density lipoprotein cholesterol (LDL-C) and increased risk of early-onset atherosclerotic cardiovascular disease. Despite treatment wi...